GÜVEN, B. Et Al. 2020. Metabolic effects of carvedilol through beta-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts. BRITISH JOURNAL OF PHARMACOLOGY , vol.177, no.24 , 5580-5594.

GÜVEN, B., Kara, Z., & BEŞİKCİ, A., (2020). Metabolic effects of carvedilol through beta-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts. BRITISH JOURNAL OF PHARMACOLOGY , vol.177, no.24, 5580-5594.

GÜVEN, BERNA, Zumra Kara, And ARZU BEŞİKCİ. "Metabolic effects of carvedilol through beta-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts," BRITISH JOURNAL OF PHARMACOLOGY , vol.177, no.24, 5580-5594, 2020

GÜVEN, BERNA G. Et Al. "Metabolic effects of carvedilol through beta-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts." BRITISH JOURNAL OF PHARMACOLOGY , vol.177, no.24, pp.5580-5594, 2020

GÜVEN, B. Kara, Z. And BEŞİKCİ, A. (2020) . "Metabolic effects of carvedilol through beta-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts." BRITISH JOURNAL OF PHARMACOLOGY , vol.177, no.24, pp.5580-5594.

@article{article, author={BERNA GÜVEN ÇİLOĞLU Et Al. }, title={Metabolic effects of carvedilol through beta-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts}, journal={BRITISH JOURNAL OF PHARMACOLOGY}, year=2020, pages={5580-5594} }